Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in Relapsing Multiple Sclerosis
NCT03183869Phase 2Terminated
- Start
- Aug 2017
- Primary completion
- Nov 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of fecal microbiome transplant in multiple sclerosis (MS). Started Aug 2017; status: terminated.
02
Drugs
fecal microbiome transplant
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03183869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03183869.